Husheng Mei
Tongji University(CN)
Publications by Year
Research Areas
Epigenetics and DNA Methylation, Ubiquitin and proteasome pathways, RNA modifications and cancer, Cancer-related gene regulation, COVID-19 Clinical Research Studies
Most-Cited Works
- → Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunities(2022)687 cited
- → Discovery of IHMT-337 as a potent irreversible EZH2 inhibitor targeting CDK4 transcription for malignancies(2023)42 cited
- → Discovery of IHMT-EZH2-115 as a Potent and Selective Enhancer of Zeste Homolog 2 (EZH2) Inhibitor for the Treatment of B-Cell Lymphomas(2021)22 cited
- → Inhibition of the deubiquitinating enzyme USP47 as a novel targeted therapy for hematologic malignancies expressing mutant EZH2(2022)19 cited
- → Repurposing clinically available drugs and therapies for pathogenic targets to combat SARS‐CoV‐2(2023)18 cited
- → Discovery of dihydropyridinone derivative as a covalent EZH2 degrader(2023)9 cited
- → Ubiquitin-specific protease 7-mediated stabilization of discoidin domain receptor 1 drives progression of TP53-Mutant cancers(2025)1 cited
- → Thoughts on practice of medical liability insurance at the hospital(2014)
- → Overcoming challenges in CAR‐T therapy for malignancies: Mechanisms and strategies(2026)
- → Targeting DESI2 as a Novel Therapeutic Strategy for JAK2‐Mutant Leukemias(2025)